Related Experiment Video
Updated: Jul 7, 2026
06:39
Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
Published on: February 18, 2020
[Coronary angioplasty: view through 30 years]
Iu N Belenkov1, A N Samko, T A Batyraliev
1Cardiology Research Complex, ul Tretiya Cherepkovskaya, 15a, Moscow, Russia.
Kardiologiia
|February 12, 2008
Summary
Percutaneous coronary interventions (PCI) have evolved significantly since 1977, becoming the leading method for coronary revascularization. Despite advancements like drug-eluting stents, challenges such as restenosis and thrombosis persist.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Context:
- The evolution of percutaneous coronary interventions (PCI) since the first successful procedure in 1977.
- PCI has become the predominant method for coronary revascularization, surpassing bypass surgery in many regions.
Purpose:
- To review the historical development and advancements in PCI techniques and technologies.
- To highlight the impact of new catheter technologies on treating complex coronary artery disease.
- To discuss the limitations and complications associated with current PCI technologies, including bare-metal and drug-eluting stents.
Summary:
- The review traces the progression of PCI from its inception, detailing improvements in equipment, pharmacological support, and procedural recommendations.
- It emphasizes the widespread adoption of PCI, with millions performed globally each year, and the rise of coronary stenting, particularly drug-eluting stents.
- Key challenges such as coronary restenosis with bare-metal stents and late thrombosis with drug-eluting stents are identified as ongoing limitations.
Impact:
- PCI is now the most common revascularization strategy for ischemic heart disease globally.
- Continued innovation in PCI is crucial for overcoming existing limitations and improving patient outcomes.
- The review provides a comprehensive overview of the successes and challenges in the field of interventional cardiology.
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:30Angina I: Introduction
Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:28Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...